Nassim Usman, Director at GYRE THERAPEUTICS, INC. (GYRE), sold 20,000 shares at $16.15 ($323K) on 2024-04-01, disclosed to the SEC on 2024-04-03.
Scheduled sale ($323k) by Director under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| Filing → |
| GYRE | SELL | 2024-03-19 | $690K | — | Filing → |
| CBIO | BUY | 2022-08-10 | $2K | — | Filing → |
| CBIO | BUY | 2022-02-16 | $1K | — | Filing → |